Literature DB >> 17227565

Biliary strictures in 130 consecutive right lobe living donor liver transplant recipients: results of a Western center.

S A Shah1, D R Grant, I D McGilvray, P D Greig, M Selzner, L B Lilly, N Girgrah, G A Levy, M S Cattral.   

Abstract

Biliary strictures remain the most challenging aspect of adult right lobe living donor liver transplantation (RLDLT). Between 04/2000 and 10/2005, 130 consecutive RLDLTs were performed in our center and followed prospectively. Median follow-up was 23 months (range 3-67) and 1-year graft and patient survival was 85% and 87%, respectively. Overall incidence of biliary leaks (n = 19) or strictures (n = 22) was 32% (41/128) in 33 patients (26%). A duct-to-duct (D-D) or Roux-en-Y (R-Y) anastomosis were performed equally (n = 64 each) with no difference in stricture rate (p = 0.31). The use of ductoplasty increased the number of grafts with a single duct for anastomosis and reduced the biliary complication rate compared to grafts >/=2 ducts (17% vs. 46%; p = 0.02). Independent risk factors for strictures included older donor age and previous history of a bile leak. All strictures were managed nonsurgically initially but four patients ultimately required conversion from D-D to R-Y. Ninety-six percent (123/128) of patients are currently free of any biliary complications. D-D anastomosis is safe after RLDLT and provides access for future endoscopic therapy in cases of leak or stricture. When presented with multiple bile ducts, ductoplasty should be considered to reduce the potential chance of stricture.

Entities:  

Mesh:

Year:  2007        PMID: 17227565     DOI: 10.1111/j.1600-6143.2006.01601.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  39 in total

1.  An extrahepatic bile duct grafting using a bioabsorbable polymer tube.

Authors:  Masayasu Aikawa; Mitsuo Miyazawa; Kojun Okamoto; Yasuko Toshimitsu; Katsuya Okada; Naoe Akimoto; Yosuke Ueno; Isamu Koyama; Yoshito Ikada
Journal:  J Gastrointest Surg       Date:  2012-01-06       Impact factor: 3.452

Review 2.  Biliary complications following liver transplantation.

Authors:  Walid S Ayoub; Carlos O Esquivel; Paul Martin
Journal:  Dig Dis Sci       Date:  2010-04-22       Impact factor: 3.199

Review 3.  Peroral cholangioscopy in the new millennium.

Authors:  Mansour A Parsi
Journal:  World J Gastroenterol       Date:  2011-01-07       Impact factor: 5.742

4.  Added value of gadoxetic acid-enhanced T1-weighted magnetic resonance cholangiography for the diagnosis of post-transplant biliary complications.

Authors:  Sonja Kinner; Tilman B Schubert; Adnan Said; Joshua D Mezrich; Scott B Reeder
Journal:  Eur Radiol       Date:  2017-04-13       Impact factor: 5.315

5.  Liver summary--IHPBA 2008.

Authors:  Oliver Farges
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

Review 6.  Management issues in post living donor liver transplant biliary strictures.

Authors:  Manav Wadhawan; Ajay Kumar
Journal:  World J Hepatol       Date:  2016-04-08

Review 7.  Benign Biliary Strictures.

Authors:  Ashley Altman; Steven M Zangan
Journal:  Semin Intervent Radiol       Date:  2016-12       Impact factor: 1.513

8.  Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium.

Authors:  Michael A Zimmerman; Talia Baker; Nathan P Goodrich; Chris Freise; Johnny C Hong; Sean Kumer; Peter Abt; Adrian H Cotterell; Benjamin Samstein; James E Everhart; Robert M Merion
Journal:  Liver Transpl       Date:  2013-03       Impact factor: 5.799

9.  Biliary complications in liver transplantation.

Authors:  See Ching Chan; Sheung Tat Fan
Journal:  Hepatol Int       Date:  2008-09-03       Impact factor: 6.047

Review 10.  Advances in endoscopic management of biliary complications after living donor liver transplantation: Comprehensive review of the literature.

Authors:  Milljae Shin; Jae-Won Joh
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.